Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The hotly anticipated results of a clinical trial of an experimental Alzheimer’s drug suggest that the treatment slowed cognitive decline somewhat for people in the early stages of the disease but also caused some patients to experience brain swelling or brain bleeding. The new data, released…
#lecanemab #alzheimer #brain #brainswelling #study #drug #placebo #percent #receiving #brainbleeding
